Composition for collecting and preserving placental stem cells and methods of using the composition
AssigneeCelularity Inc.
InventorsJames W. Edinger, Mohammad Heidaran, Wolfgang Hofgartner
Life of this patent
Estimating the term…
Abstract
The present invention provides improved compositions and methods for the collection of stem cells from an organ, e.g., placenta. The invention provides a stem cell collection composition comprising an apoptosis inhibitor and, optionally, an enzyme such as a protease or mucolytic enzyme, vasodilator, necrosis inhibitor, oxygen-carrying perfluorocarbon, or an organ preserving compound. The invention provides methods of using the stem cell collection composition to collect stem cells and to preserve populations of stem cells.
Claims20
A method of isolating stem cells from a population of cells with which the stem cells are normally associated with in an intact organ, comprising contacting said stem cells with a solution comprising a caspase inhibitor, a JNK inhibitor and a protease,
- wherein the JNK inhibitor is an inhibitor of apoptosis, said JNK inhibitor is represented by the structure
- wherein:
- R1 is aryl or heteroaryl optionally substituted with one to four substituents independently selected from R7;
- R2 is hydrogen;
- R3 is hydrogen or lower alkyl;
- R4 represents one to four optional substituents, wherein each substituent is the same or different and independently selected from halogen, hydroxy, lower alkyl and lower alkoxy;
- R5 and R6 are the same or different and independently —R8, —(CH2)aC(═O)R9—, —(CH2)aC(═O)OR9, —(CH2)aC(═O)NR9R10, —(CH2)aC(═O)NR9(CH2)bC(═O)R10, —(CH2)aNR9C(═O)R10, (CH2)aNR11C(═O)NR9R10, —(CH2)aNR9R10, —(CH2)aOR9, —(CH2)aSOcR9 or —(CH2)aSO2NR9R10;
- or R5 and R6 taken together with the nitrogen atom to which they are attached to form a heterocycle or substituted heterocycle;
- R7 is at each occurrence independently halogen, hydroxy, cyano, nitro, carboxy, alkyl, alkoxy, haloalkyl, acyloxy, thioalkyl, sulfinylalkyl, sulfonylalkyl, hydroxyalkyl, aryl, arylalkyl, heterocycle, substituted heterocycle, heterocycloalkyl, —C(═O)OR8, —OC(═O)R8, —C(═O)NR8R9, C(═O)NR8OR9, —SOcR8, —SOcNR8R9, —NR8SOcR9, —NR8R9, —NR8C(═O)R9, —NR8C(═O)(CH2)bOR9, —NR8C(═O)(CH2)bR9, —O(CH2)bNR8R9, or heterocycle fused to phenyl:
- R8, R9, R10 and R11 are the same or different and at each occurrence independently hydrogen, alkyl, aryl, arylalkyl, heterocycle, heterocycloalkyl;
- or R8 and R9 taken together with the atom or atoms to which they are attached to form a heterocycle;
- a and b are the same or different and at each occurrence independently selected from 0, 1, 2, 3 or 4;
- and
- c is at each occurrence 0, 1 or 2;
- or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, enantiomer, diastereomer, racemate, or mixture of stereoisomers thereof.
Dependencies are inferred from the claim text.